 | Andreas Pinterfor the IXORA-PEDS Investigators | Clinic for Dermatology, Venereology and Allergology, University Hospital Frankfurt am Main, Frankfurt, Germany | Department of Dermatology, ... |
Is this your profile? Claim your profile Copy URL Embed Link to your profile |
Andreas Pinter:Expert Impact
Concepts for whichAndreas Pinterhas direct influence:Hidradenitis suppurativa,Lichen planus,Patients hidradenitis suppurativa,Clindamycin rifampicin,Treatment hidradenitis,Patients hidradenitis,Suppurativa humans.
Andreas Pinter:KOL impact
Concepts related to the work of other authors for whichfor which Andreas Pinter has influence:Hidradenitis suppurativa,Lichen planus,Skin microbiome,Rna therapeutics,Patients biologic therapy,Vivo culture,Lipid nanoparticle.
KOL Resume for Andreas Pinter
| Year | |
|---|---|
| 2022 | for the IXORA-PEDS Investigators |
| 2021 | Department of Dermatology, Venereology and Allergology, University Hospital Frankfurt am Main, Germany. |
| 2011 | Klinik für Dermatologie, Allergologie und Venerologie, Klinikum der J.W. Goethe‐Universität |
Prominent publications by Andreas Pinter
BACKGROUND: Tetracyclines and clindamycin plus rifampicin combination therapy are both considered first-line therapy in current hidradenitis suppurativa guidelines. However, evidence for their efficacy is drawn from small studies, often without validated outcomes.
OBJECTIVE: To assess the 12-week efficacy of oral tetracyclines and a combination of clindamycin and rifampicin.
METHODS: A prospective, international cohort study performed between October 2018 and August 2019.
RESULTS: In ...
| Known for Hidradenitis Suppurativa | Clindamycin Rifampicin | Patient Characteristics | 12 Weeks |
